MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Symptomatic delayed-onset edema following deep brain stimulation for Parkinson’s disease: occurrence, symptoms, management and outcomes. Experience of a single center.

    B. Minafra, NG. Pozzi, M. Picascia, R. Zangaglia, F. Bruschi, F. Avantaggiato, M. Todisco, D. Servello, C. Pacchetti (Pavia, Italy)

    Objective: To report on occurrence, symptoms, management and outcomes of SDE following DBS of either the subthalamic nucleus (STN) or Globus pallidum interna nucleus (GPi)…
  • 2019 International Congress

    Impact of Nordik Walking training in patients with Progressive Supranuclear Palsy

    R. Kandel, B. Bhattarai (Lalitpur, Nepal)

    Objective: To evaluate the effects of  Nordik Walking training on  functional mobility, upper limb strength, falls and mood in patients with mild  Progressive Supranuclear Palsy…
  • 2019 International Congress

    Exposed-Only Analysis of Gene-Pesticide Interaction in Parkinson’s Disease (PD)

    J. Kaye, L. Lima, C. Tanner, S. Finkbeiner, R. Swanson, S. Goldman (San Francisco, CA, USA)

    Objective: Assess gene-pesticide associations with PD using an exposed-only design in a highly exposed cohort. Background: Pesticide use is associated with an increased risk of…
  • 2019 International Congress

    Applicability of questionnaires and study of the prevalence of REM Sleep Behavior Disorder (RBD) in Parkinson’s disease

    M. Cordellini, A. Machado, C. Costa (Curitiba, Brazil)

    Objective: Evaluation of patients with idiopathic Parkinson's disease regarding the presence of RBD, application of the questionnaires, and correlation between the diagnosis of RBD by…
  • 2019 International Congress

    Predictors of refractory impulse control disorder to dopamine agonists substitution therapy in Parkinson’s disease patients

    JY. Lee, J-H. Choi, B. Jeon, J. Cho (Seoul, Republic of Korea)

    Objective: This study was aimed to investigate a predictive factor of refractory impulse control disorder (ICD) in patients with Parkinson’s disease (PD) who participated in…
  • 2019 International Congress

    Neuroanatomical and Electrocortical Networks correlates in Parkinson’s Disease Patients with Mild Cognitive Impairment:The PaCoS Study

    G. Donzuso, G. Giuliano, R. Monastero, R. Baschi, G. Mostile, A. Luca, C. Cicero, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: Aim of the study is to evaluate the presence of grey matter (GM) and electrocortical changes in Pd patients with MCI. Background: Mild cognitive…
  • 2019 International Congress

    Diagnostic potential of automated diffusion imaging for the differential diagnosis of multiple system atrophy and Parkinson’s disease

    F. Krismer, V. Beliveau, K. Seppi, G. Goebel, G. Wenning, E. Gizewski, W. Poewe, C. Scherfler (Innsbruck, Austria)

    Objective: To evaluate the diagnostic potential of an automated diffusion imaging (DWI) analyses pipeline in separating patients with multiple system atrophy (MSA) and Parkinson’s disease…
  • 2019 International Congress

    Comparison of PDE10A and DAT expression as markers of disease burden in early Parkinson’s disease

    G. Pagano, H. Wilson, T. Yousaf, F. Niccolini, N. Khan, D. Martino, R. Gunn, E. Rabiner, P. Piccini, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to compare loss of PDE10A and DAT expression in patients with Parkinson’s disease. Background: Recent work has shown loss of PDE10A expression…
  • 2019 International Congress

    Regional subcortical volumes predict gait decline in early Parkinson’s disease

    J. Wilson, R. Lawson, B. Galna, A. Yarnall, S. Lord, R. Morris, L. Alcock, G. Duncan, T. Khoo, D. Burn, L. Rochester, J-P. Taylor (Newcastle Upon Tyne, United Kingdom)

    Objective: To predict changes in discrete gait characteristics in early Parkinson’s disease (PD) compared to healthy ageing, using subcortical brain volumes quantified in early disease.…
  • 2019 International Congress

    Blue light therapy glasses in Parkinson’s disease: patients’ experience and effectiveness

    K. Smilowska, D. van Wamelen, A. Schoutens, M. Meinders, B. Bloem (Nijmegen, Netherlands)

    Objective: We aimed to assess how patients experience the use of blue light glasses, a novel way of delivering light therapy, aiming to optimise compliance…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • #24752 (not found)
    • Effect of Aspartame on Parkinson’s Disease Progression and Severity
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley